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Conclusions: Asian women who are nonobese are more insulin-sensitive than men at the level of adipose tissue but not skeletal muscle. Therefore, sex differences in glucose tolerance are likely the result of sexual dimorphism in hepatic insulin action. (J Clin Endocrinol Metab 104: [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] 2019) T he prevalence of type 2 diabetes (T2D) has been increasing during the past two to three decades in many Asian countries, including Singapore, and is expected to continue to increase in the foreseeable future (1) . The incidence of diabetes in Asians aged $20 years is lower in women than in men by~15% to 35% (2, 3) . Accordingly, sex differences are present in many risk factors associated with the development of T2D, such as body composition, fasting and postprandial glucose concentrations, circulating nonesterified fatty acids (NEFAs), plasma lipid profile, and blood pressure (3, 4) . However, the mechanisms underlying these differences are not well understood.
Diabetes in Asia occurs, to a considerable extent, in the absence of obesity;~40% of newly diagnosed cases occur in lean people with an average body mass index (BMI) of 21.9 kg/m 2 , without any weight gain (5) . This corroborates the observation that, in Singapore, the prevalence of T2D is similar to that in the United States, although the combined prevalence of overweight and obesity (BMI $ 25 kg/m 2 ) is approximately one half (6) . Although much work has been done to understand the obesity-related metabolic dysfunction leading to T2D (7), comparably less is known about the regulation of glucose metabolism in the absence of obesity.
According to the prevailing line of thought, peripheral insulin sensitivity decreases many years before the diagnosis of T2D; however, this reduced insulin action is being countered by a compensatory increase in pancreatic insulin secretion. The resulting hyperinsulinemia maintains glucose homeostasis. However, gradually, the b-cells cannot keep up with the increased demand for insulin and eventually fail. As a result, insulin secretion diminishes and fasting and postprandial hyperglycemia develop (8) . Differences between men and women in this complex interplay between the mechanisms regulating plasma glucose homeostasis, especially among Asians who are nonobese, remain incompletely understood. Therefore, we used state-of-the-art imaging techniques and metabolic function tests to assess sex differences in body composition, insulin sensitivity, and insulin secretion in normal weight Asian subjects.
Methods

Participants
A total of 32 Asian men and 28 Asian women (aged 21 to 65 years) with normal body weight (BMI, 19.0 to 24.7 kg/m 2 )
participated in the present study. All subjects were apparently healthy and had no history of underlying medical conditions, such as diabetes, hypertension, dyslipidemia, substantial organ system dysfunction, or other metabolic diseases that require the use of drugs for treatment. Volunteers who used tobacco products, consumed alcohol regularly ($1 unit/day), used any medications known to affect metabolic function (including oral contraceptives and hormone replacement therapy), had experienced a recent weight loss or gain ($5 % during the previous 6 months), and women who were pregnant or breastfeeding or had polycystic ovary syndrome were excluded from the present study. Individuals with any contraindications to exercise, including musculoskeletal, respiratory, or circulatory disorders, were also excluded. All participants provided their written informed consent before enrollment, and ethics approval was obtained from the Domain Specific Review Board of the National Health Care Group in Singapore.
Body composition and fat distribution
The percentage of body fat, fat mass, and fat-free mass (FFM) were assessed by dual-energy X-ray absorptiometry using a Discovery QDR Series dual-energy X-ray absorptiometry scanner (Hologic, Bedford, MA). Abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) volumes were measured by MRI. Intrahepatic triglyceride (IHTG) and intramyocellular lipid (IMCL) contents were determined using 1 H magnetic resonance spectroscopy on a 3T scanner (Tim Trio; Siemens, Erlangen, Germany), as previously described (9, 10) . IHTG was expressed as the ratio of fat to fat plus water (percentages), and IMCL was expressed as the ratio to creatine (arbitrary units). Expressing IMCL relative to creatine or water provided equivalent results (11, 12) .
Cardiorespiratory fitness
Aerobic fitness was determined by conducting breath-bybreath analysis of oxygen consumption and carbon dioxide production using a CareFusion Vmax Encore metabolic cart (Becton, Dickinson, and Company, Franklin Lakes, NJ) during a graded exercise test to exhaustion on a cycloergometer (Monark 839E Digital Ergomedic; Monark Exercise AB, Vansbro, Sweden).
Handgrip strength
Handgrip strength of the dominant arm was measured in triplicate using a digital dynamometer (Jamar Plus+ Digital Hand Dynamometer; Patterson Medical, Chicago, IL), and the average value (in kilograms) was used for analysis.
Metabolic function
Metabolic tests were conducted at the Clinical Nutrition Research Centre, National University of Singapore, on two additional occasions, scheduled~1 week apart. One day before testing, the participants were instructed to fast overnight from 10:00 PM and to abstain from consuming alcohol and caffeine. All individuals were asked to maintain their usual dietary habits and avoid strenuous physical activity for the preceding 3 days. The subjects arrived in the laboratory in the morning (8:00 AM), and their vital signs (blood pressure, heart rate, and temperature) were obtained after 30 minutes of bed rest, before any testing began.
Hyperinsulinemic-euglycemic clamp
Insulin sensitivity was assessed as the insulin-mediated whole-body glucose uptake divided by the steady-state insulin concentration, evaluated using a 4-hour hyperinsulinemiceuglycemic clamp (10) . An indwelling catheter was inserted into a hand vein of one arm for repeated blood sampling. The hand was heated to 50°C with the use of a thermostatically controlled box for sampling arterialized blood. A second catheter was inserted into an antecubital vein of the contralateral arm for infusion of insulin (Actrapid; Novo Nordisk A/S, Bagsvaerd, Denmark) and 20% dextrose. After collection of baseline fasting blood samples, insulin was infused continuously at a rate of 40 mU/m 2 body surface area/min for the duration of the clamp. The plasma glucose concentration was measured at 10-minute intervals, and the infusion rate of 20% dextrose was adjusted accordingly to maintain euglycemia (5.5 mmol/L).
Mixed meal tolerance test
Pancreatic insulin secretion was assessed as the total amount of insulin secreted in response to ingestion of a standardized mixed meal (10) . Blood samples were obtained from an indwelling catheter inserted into a forearm vein of one arm. After the baseline fasting blood samples were obtained (at time 0), the participants consumed a 2510 kJ (600 kcal) liquid mixed meal over 5 minutes (54% of energy from carbohydrate, 17% from protein, and 29% from fat; Ensure Plus, Abbott Nutrition, Lake Forest, IL). Postprandial blood samples were collected at 10, 20, 30, 45, 60, 90, 120, 150 , and 180 minutes to measure plasma concentrations of glucose, C-peptide, and insulin.
Biochemical analyses
The plasma glucose concentration was determined using the glucose oxidase method on an automated glucose analyzer (YSI 2300 Stat Plus; YSI Life Sciences, Yellow Springs, OH). The plasma insulin and C-peptide concentrations were measured using commercially available electrochemiluminescence assays (Roche/Hitachi cobas e411 immunochemistry analyzer; Roche Diagnostics, Indianapolis, IN). The total plasma triglyceride, total cholesterol, low-density lipoprotein cholesterol, and highdensity lipoprotein (HDL) cholesterol concentrations, and glycated hemoglobin were determined by standard methods at the National University Hospital Referral Laboratory (accredited by the College of American Pathologists). The serum NEFA concentrations were determined using an enzymatic colorimetric method (Wako Diagnostics, Mountain View, CA). Plasma leptin, adiponectin (R&D Systems, Minneapolis, MN), gastric inhibitory polypeptide (GIP), and glucagon-like peptide-1 (GLP-1; EMD Millipore, Billerica, MA) concentrations were measured using commercially available ELISA kits.
Calculations
Whole-body insulin sensitivity
Insulin-mediated whole-body glucose disposal (M-value; in milligrams of glucose per kilograms of FFM per minute) was calculated as the average rate of dextrose infusion during the final 30 minutes of insulin infusion (steady state of the clamp). Insulin sensitivity was assessed as the M/I ratio (i.e., glucose disposal divided by the average plasma insulin concentration during the final 30 minutes of the clamp), which adjusts wholebody glucose uptake for potential differences in steady-state insulin concentrations attained during the clamp (10).
Pancreatic insulin secretion
The insulin secretion rate (ISR; pmol/L/min) before and after the ingestion of the mixed meal was assessed using oral minimal model analysis of plasma C-peptide and glucose concentrations (Simulation, Analysis and Modeling Software; SAAM II version 2.3; The Epsilon Group, Charlottesville, VA) (13) . This model provides the basal (fasting) ISR, static ISR (ISR response to plasma glucose concentration), dynamic ISR (ISR response to the rate of increase in plasma glucose), and total ISR (overall ISR response to plasma glucose) (13) . Cumulative postprandial ISRs (in pmol/L) were computed as the corresponding areas under the curve (AUCs) for 180 minutes after ingestion of the mixed meal.
Disposition index
The disposition index, which provides an assessment of pancreatic insulin secretion in relation to peripheral insulin sensitivity, was calculated as the product of the M/I ratio (clamp) and total ISR AUC [mixed meal tolerance test (MMTT)] (14).
Insulin clearance
The postprandial insulin clearance rate (in L/min; MMTT) was determined as the total postprandial ISR AUC divided by the insulin concentration AUC and multiplied by the C-peptide volume of distribution. The steady-state insulin clearance rate (in L/min; clamp) was determined as the exogenous insulin infusion rate divided by the steady-state plasma insulin concentration (10).
Adipose tissue insulin sensitivity
The sensitivity of adipose tissue lipolysis to meal ingestion was evaluated as the maximum percentage of suppression of serum NEFA from baseline values (i.e., fasting concentration minus nadir concentration), and as the cumulative change in NEFA concentrations over the whole postprandial period (change in AUC over fasting levels).
Statistical analysis
All analyses were performed using SPSS, version 23 (IBM Corp., Armonk, NY). The Shapiro-Wilk test was used to evaluate the normality of the data distributions. Differences between men and women were assessed using the Student independent t test for normally distributed data or the MannWhitney U test for non-normally distributed data, and the results are presented as the mean 6 SD or the median and quartiles, respectively. Statistical significance was set at P , 0.05 based on two-sided tests.
Results
The men and women were matched for age and BMI. Women had a greater body fat percentage and fat mass and lower lean mass than men (Table 1) . They also had 30% lower VAT and~25% greater SAT than men, and the latter was entirely due to deep SAT (~60% greater in women than in men). Superficial SAT, IHTG, and IMCL contents were not significantly different between the sexes (Table 1) . Compared with men, the women had lower systolic blood pressure, lower maximal oxygen uptake (VO 2 max), and lower handgrip strength. However, the diastolic blood pressure and heart rate at rest were not different between the men and women ( Table 1) .
Women had greater HDL cholesterol, leptin, and adiponectin concentrations than men. However, no sex differences were found in total and low-density lipoprotein cholesterol and triglyceride concentrations, glycated hemoglobin, or fasting insulin, GIP, and GLP-1 concentrations (Table 2) . Women tended to have a lower fasting glucose (P = 0.06) and higher serum NEFA concentrations (P = 0.09) than men; however, the differences did not reach statistical significance (Table 2) .
In response to mixed meal ingestion, the glucose AUC was~8% lower in women than in men (P = 0.048). In contrast, insulin, GIP, and GLP-1 AUCs were not different (Fig. 1 ). Women and men were clamped at identical glucose concentrations (101 6 1 and 100 6 1 mg/ dL; P = 0.621). Insulin-mediated whole-body glucose disposal (M-value) was~16% greater in women than in men (P = 0.018; Fig. 2) ; however, this difference was abolished when considering the M/I ratio (P = 0.558; Fig. 2 ), likely because the steady-state insulin concentration tended to be greater in women than in men (91 6 24 and 82 6 19 mU/L, respectively; P = 0.103).
The basal, static, dynamic, and total postprandial ISRs were not different between the women and men (P . 0.2 for all; Fig. 2 ). The postprandial insulin clearance rate (estimated from the MMTT) was not different between the sexes (P = 0.369); however, the steady-state insulin clearance rate (estimated from the clamp) was~17% lower in women than in men (P = 0.003; Fig. 2 ). The disposition index was not significantly different between the sexes (P = 0.553; Fig. 3 ). The meal-induced suppression of the circulating NEFA concentrations was substantially greater in women than in men (Fig. 4) .
Discussion
In the present study, we evaluated body composition, fat distribution, physical fitness, and glucose and fatty acid metabolism in healthy Asian men and women who were nonobese. As expected (15, 16) , for the same BMI, Asian women had more total body fat and SAT but less VAT than did men. Also, we observed that women were less physically fit (lower VO 2 max and handgrip strength) than men. However, we did not find any differences in ectopic fat deposition (IMCL and IHTG contents) or in postprandial insulin secretion and clearance rates. We did find that adipose tissue insulin sensitivity (mealinduced suppression of NEFA concentrations; MMTT) was greater in women than in men. Insulin-mediated whole-body glucose disposal (which predominantly reflects uptake into skeletal muscle) was greater in women than in men; however, this difference was entirely due to differences in steady-state insulin concentrations, owing to differences in steady-state insulin clearance. Our results suggest sexual dimorphism in the regulation of glucose and fatty acid metabolism among Asians who are nonobese, which might be one of the reasons for the lower incidence of diabetes in Asian women than in Asian men (2, 3), although many more factors could be responsible.
A number of studies have used the hyperinsulinemic euglycemic clamp technique to evaluate sex differences in insulin sensitivity between men and women. Although insulin-mediated glucose uptake (M-value) is typically lower in women than in men at the whole body level and not different between the sexes when normalized per kilogram of total body weight (17) (18) (19) (20) (21) (22) (23) (24) (25) , the M-values normalized per kilogram of muscle mass, FFM, or lean mass have been reported to be 20% to 110% greater in women than in men, regardless of the BMI (lean, overweight, or obese), age (young or old), and race (white or black) (20, 22, (26) (27) (28) (29) (30) (31) (32) . Our findings are consistent with these observations and, for the first time to the best of our knowledge, have documented this female advantage in insulin-mediated glucose disposal among Asians. Only two studies have failed to find a statistically significant sex difference in glucose uptake normalized for lean mass, although in both studies, the M-values were~10% greater in women than in men (33, 34) . The generally lower aerobic fitness (VO 2 max) of women (34), but not their lower muscle strength (31), might be linked to the variations across the studies in the magnitude of sexual dimorphism in M-value, as suggested by studies that recruited groups of men and women matched for VO 2 max (20, 26) . The women in our study had a significantly lower VO 2 max than the men, and the difference in glucose disposal between the sexes (~16%) was at the low end of the range reported in other populations (20% to 110%) (20, 22, (26) (27) (28) (29) (30) (31) (32) . We are aware of only one previous study of Asian men and women from Thailand who were overweight and obese that reported no sex differences in the M-value adjusted for total body weight (23) . However, FFM was not assessed in that study. It is important to note that glucose disposal during insulin infusion refers to the uptake of glucose by all insulin-sensitive tissues of the body. Skeletal muscle accounts for 70% to 85% of whole-body glucose disposal under these conditions (35, 36) . Studies that used the arteriovenous balance technique across the femoral and forearm muscles reported 30% to 60% greater muscle glucose uptake rates in women than men (26, 32, 37) , in agreement with the results for whole-body M-values adjusted for lean mass (20, 22, (26) (27) (28) (29) (30) (31) (32) . This sexual dimorphism in insulin-mediated glucose disposal could not be explained by differences in the intramuscular lipid metabolites that have been linked to disrupted insulin action (e.g., triacylglycerol, diacylglycerol, and ceramide) (27) , in the expression of glucose transporter 4, insulin receptor, or Akt expression and phosphorylation in muscle (32) or in the number and affinity of insulin receptors in circulating mononuclear blood cells (28) . We did not detect any differences in fat accumulation in muscle and liver between the sexes, in line with earlier studies that had dissociated sex differences in IMCL and IHTG contents from insulin sensitivity (32, 33, 38, 39) . Furthermore, we observed that adjusting M-values for the steady-state insulin concentrations attained during the clamp abolished the sex differences in muscle glucose disposal, because of the lower steady-state insulin clearance rates in women than in men, which led to somewhat greater steady-state insulin concentrations. This raises the possibility that the greater glucose uptake rates in Asian women who were nonobese than men might have resulted from a greater stimulus (i.e., more circulating insulin), rather than resulting from true sexual dimorphism in peripheral insulin sensitivity. Previous studies that found greater M-values in women than in men in other populations did not report the M/I ratios, although most observed similar or somewhat lower steadystate insulin concentrations in women than in men (20, 26, 27, (31) (32) (33) 40) . In one study that did report the M/I ratios, however, the sexual dimorphism in insulin-mediated glucose disposal was abolished (31), just as in our study. It remains unclear, therefore, whether M-value adjusted for circulating insulin (i.e., insulin sensitivity) exhibits sexual dimorphism in non-Asian populations. We found that the meal-induced suppression of circulating NEFA concentrations is greater in our Asian women than in our Asian men. Although NEFA concentrations only indirectly reflect adipose tissue lipolysis rates, a good correlation was found between the NEFA concentration and NEFA rate of appearance in plasma (which is a more direct measure of adipose tissue lipolysis) in both fasting and postprandial states (25) . Our findings, therefore, imply that adipose tissue insulin sensitivity is greater in women than in men. This agrees with the results from previous studies, which reported greater suppression of NEFA concentrations or NEFA rates of appearance in plasma in women than in men after a standard glucose load or mixed meal or during insulin infusion (29, 37, (41) (42) (43) (44) . This sex difference was observed in individuals who were both obese and nonobese and across various ethnicities (whites, blacks, Asian Indians) (29, (41) (42) (43) (44) and was attributed to a more insulin-resistant upper body SAT in men compared with women (41). However, not all studies have reached the same conclusion (25, 26, (45) (46) (47) . Some of this discrepancy could have resulted from the degree of hyperinsulinemia achieved in different studies, which used oral glucose or meal challenges or insulin infusion at different rates. Lipolysis is very sensitive to insulin and almost completely suppressed at relatively low insulin concentrations. Therefore, although differences might exist between men and women in the sensitivity of adipose tissue lipolysis at lower insulin concentrations, these differences might be abolished at higher insulin concentrations (48, 49) . This possibility is in line with the results from rodent studies showing that downstream insulin signaling phosphorylation events in adipose tissue are more robust in females than in males on stimulation by low physiological insulin concentrations. However, this sexually dimorphic response is abolished at greater insulin concentrations (50) . Nevertheless, a dose-response study with stepwise insulin infusion rates revealed that the plasma insulin concentration at which adipose tissue NEFA release is half maximally suppressed is similar in men and women (47) . Additionally, the same absolute glucose or meal challenge represents a greater challenge for women than men relative to their body size, and this could be associated with the greater suppression of circulating NEFA in women (49) .
This same reasoning, however, cannot explain the lower glucose AUC we observed in our Asian women compared with our Asian men. Administering the same absolute glucose load would be consistent with greater, not lower, glucose concentrations in women than in men after standard oral glucose tolerance tests (owing to the greater glucose load relative to body size in women than in men), and the disappearance of this difference when adjusted for body size (51, 52) . Previous studies that used the oral glucose tolerance test to evaluate differences between men and women matched for age and BMI reported equivocal results; most found lower glucose responses in women than in men (29, (53) (54) (55) (56) , just as we did. However, some found no differences (57, 58) . The corresponding insulin responses were mostly similar (29, 37, (54) (55) (56) (57) (58) or occasionally greater (18, 53) in women than in men. These results are difficult to interpret because a fixed carbohydrate challenge (used in standard oral glucose or MMTTs) does not account for differences in body size between the sexes. More importantly, solely relying on glucose and insulin concentrations cannot discriminate among insulin sensitivity, insulin secretion, and insulin clearance in regulating glucose homeostasis. In the present study, we used a MMTT with mathematical modeling of C-peptide and glucose concentrations (10, 13, 59) . We found no sex differences in the postprandial insulin secretion and clearance rates. We also did not observe any sex differences in fasting and postprandial incretin concentrations (GIP and GLP-1), which are known to potentiate glucose-induced insulin secretion after carbohydrate ingestion. Likewise, an earlier study that used a very similar method (mixed meal test allocated per kilogram of body weight in conjunction with the oral C-peptide minimal model) found no differences between young men and women or elderly men and women in the indexes of static, dynamic, and total insulin secretion and hepatic insulin extraction (16) . In contrast, glucose-induced insulin secretion measured using the intravenous glucose tolerance test (with glucose challenges adjusted for body size) has been reported to be greater (60, 61) , not different (62, 63) , or lower (64) in women than in men. The reasons for these discrepant results are not readily apparent.
Our Asian women who were nonobese had lower postprandial glucose concentrations compared with the men (i.e., better glucose tolerance; MMTT). However, the muscle insulin sensitivity (M/I ratio; clamp) and postprandial insulin secretion (MMTT/modeling) were not different. Accordingly, this translated into a similar disposition index. However, our disposition index is not the original disposition index derived from minimal modeling of intravenous glucose tolerance test data and might, thus, not share all of its properties or have the same relationship with glucose tolerance. Our data imply that the more efficient regulation of glucose homeostasis in women than in men rests on differences in insulin action in tissues other than skeletal muscle. For example, women are more sensitive than men to the effects of insulin in the liver and suppress endogenous glucose production to a greater extent than in men at low insulin concentrations, although the maximal insulin-mediated suppression at high insulin concentrations is not different between the sexes (49) . Sexual dimorphism in other parameters of glucose metabolism, such as glucose absorption or hepatic insulin extraction (16, 65, 66 ) is small and unlikely to contribute to the observed sex differences in glucose tolerance.
To the best of our knowledge, our study is the first to describe sex differences in body composition, ectopic fat deposition, and metabolic function in Asians who are nonobese. Nevertheless, our study was not without limitations. First, the actual BMI cutoffs for identifying "overweight" and "obese" subjects are lower for most Asian populations than those for whites (although variability exists among the different Asian populations themselves) (67) . For Singaporeans, it has been proposed that a BMI of 26 to 27 kg/m 2 should be used to identify "obese" subjects (68), which was greater than our maximum BMI inclusion limit (,25 kg/m 2 ). Therefore, some of our subjects might have been "overweight"; however, matching men and women for BMI should eliminate the effect of this uncertainty on our results. Nevertheless, given that our population of subjects who were nonobese had lower global risk profile than their obese counterparts, we cannot exclude the possibility that our results should not be generalized for Asians who are obese or other ethnic populations. Second, we did not account for menstrual cycle phase or menopausal status in women. However, carefully controlled studies on the effects of menstrual cycle, menopause, and exogenous sex hormone administration have provided little-if anyindication that differences in the sex hormone milieu could be responsible for the differences between men and women in basal and insulin-mediated glucose (49) and NEFA (48) metabolism. Furthermore, we used a "cold" clamp technique to measure insulin sensitivity, which does not allow for the separate assessment of hepatic insulin action. Therefore, we could not account for the contribution of incompletely suppressed hepatic glucose production to whole-body glucose disposal. Larger and more elaborate studies, perhaps involving two-stage clamps with glucose tracer infusions or pancreatic clamps, should be performed to confirm our observations. In conclusion, our results have indicated that Asian women who are nonobese have better glucose tolerance and greater M-value but similar muscle insulin sensitivity and greater meal-induced suppression of NEFA availability (an index of adipose tissue insulin sensitivity) than Asian men who are nonobese, without any differences in fat accumulation in liver and muscle. Furthermore, we found no differences in postprandial insulin secretion and clearance rates in response to a mixed meal. These findings suggest at least some degree of sexual dimorphism is present in glucose and fatty acid metabolism, which could have been responsible for the lower incidence of T2D in Asian women than in Asian men.
